Prior Authorization for Infusion Therapy: A Patient’s Complete Guide

Prior authorization (PA) is an insurance requirement that your health plan must approve certain medications or treatments before they are covered. For infusion therapy patients, this process can delay treatment by 5 to 15 business days or longer. Understanding the PA process, knowing what documentation your insurer needs, and preparing to appeal a denial can mean the difference between timely treatment and costly gaps in care.

What Is Prior Authorization?

Think of prior authorization as a permission slip. Before an insurance company agrees to pay for an infusion medication, it wants to confirm that the treatment is medically necessary, appropriate for the diagnosis, and falls within the plan’s coverage guidelines. The prescribing physician’s office submits this request on the patient’s behalf.

For infusion therapies like IVIG (intravenous immunoglobulin), biologic medications, and specialty drugs, prior authorization is nearly universal. These treatments can cost thousands of dollars per infusion, which is precisely why insurers scrutinize them more closely than a standard prescription.

The term “prior authorization” may also appear as “pre-certification,” “pre-approval,” or “prior approval” on insurance paperwork. They all mean the same thing: the insurer must say yes before treatment begins.

Why Do Insurers Require Prior Authorization?

Insurance companies frame prior authorization as a tool for ensuring patients receive safe, evidence-based care. In practice, it also functions as a cost-control measure. According to the American Medical Association, 94% of physicians report that prior authorization delays access to necessary care.

Insurers use PA to verify that:

• The diagnosis matches an FDA-approved or evidence-supported indication for the drug
• Less expensive alternatives have been tried or considered (this is called step therapy)
• The treatment setting is appropriate, such as home infusion versus hospital outpatient
• The dose and frequency align with clinical guidelines

Typical Prior Authorization Timeline

How long does prior authorization take? The answer depends on the type of request and the insurer, but here are general benchmarks:

What Happens During the Review

Once the PA request is submitted, an insurance reviewer, often a nurse or pharmacist, compares the submitted information against the plan’s medical policy for that drug. They are checking boxes on a criteria list. Does the patient have the right diagnosis? Were prerequisite treatments attempted? Is the requested dose within accepted ranges?

If all the criteria are met, the PA is approved. If something is missing or unclear, the insurer may request additional information, which restarts the clock. This is one of the most common reasons for delays: incomplete submissions that trigger back-and-forth requests.

When the clinical reviewer cannot approve the request based on initial documentation, it escalates to a medical director, a physician employed by the insurance company, who makes the final determination.

Required Documentation

Strong documentation is the single most important factor in getting a PA approved quickly. Most insurers require:

• Clinical notes from the prescribing specialist, including physical exam findings, lab results, and imaging
• Confirmed diagnosis with ICD-10 codes that match the drug’s approved indications
• Treatment history showing which medications have been tried and why they were inadequate or not tolerated
• A letter of medical necessity from the treating physician explaining why this specific infusion therapy is needed
• Relevant lab work such as immunoglobulin levels, antibody titers, nerve conduction studies, or inflammatory markers
• Peer-reviewed literature supporting off-label use, if the drug is being prescribed for an indication not yet FDA-approved

Common Denial Reasons

Knowing why PAs get denied helps patients and providers avoid preventable roadblocks. The most frequent denial reasons include:

1. Incomplete documentation: Missing lab results, outdated clinical notes, or absent treatment history. This is the most fixable reason for denial.
2. Step therapy not met: The insurer requires that a less expensive drug be tried first. Learn more about step therapy requirements for biologics.
3. Diagnosis not meeting criteria: The submitted diagnosis code does not match the insurer’s approved list of indications for the drug.
4. Site of care: The insurer wants the infusion administered in a less costly setting than what was requested. Read about site of care optimization to understand this trend.
5. Dosing outside guidelines: The requested dose or frequency exceeds the insurer’s clinical criteria.
6. Expired authorization: Treatment continued past the approved authorization period without renewal.

A denial letter must include the specific clinical reason for the denial and instructions on how to appeal. If it does not, contact the insurer and request this information in writing. You are legally entitled to it.

Peer-to-Peer Review

When a PA is denied, the prescribing physician can request a peer-to-peer review. This is a phone call between your doctor and the insurance company’s medical director. It is one of the most effective tools for overturning a denial, yet many doctors do not request it unless the patient specifically asks.

During the peer-to-peer call, your doctor can explain the clinical nuances that do not always come through in paperwork: why a particular patient cannot tolerate the preferred drug, why the disease is progressing despite first-line treatment, or why a specific dosing schedule is necessary.

Appeal Levels and Your Rights

Every patient has the legal right to appeal a prior authorization denial. The appeal process typically has multiple levels:

Level 1: Internal Appeal

This is the first formal appeal, submitted to the insurance company itself. You generally have 30 to 180 days to file, depending on the plan. Submit additional documentation, updated clinical notes, and a revised letter of medical necessity. A different reviewer at the insurance company must evaluate the appeal.

Level 2: Second Internal Appeal (If Available)

Some plans offer a second internal review. This is often conducted by an independent panel within the insurer.

Level 3: External Review

If internal appeals are exhausted, you have the right to an external review by an independent third-party organization. The external reviewer is not employed by your insurance company. Under the Affordable Care Act, all non-grandfathered health plans must offer external review. The external reviewer’s decision is binding on the insurer.

State Insurance Commissioner

If you believe your insurer is acting in bad faith or violating state insurance regulations, you can file a complaint with your state insurance commissioner. This does not replace the appeal process, but it creates a regulatory record and can sometimes prompt faster resolution.

Tips for Faster Prior Authorization Approval

Patients who take an active role in the PA process tend to experience shorter delays. Here are concrete steps that make a difference:

• Ask for the insurer’s specific PA criteria. Call the number on the back of your insurance card and request the clinical policy for your medication. Knowing exactly what the insurer is looking for helps your doctor tailor the submission.
• Confirm your doctor’s office submitted the request. PA submissions can fall through the cracks in busy practices. Call two business days after your appointment to verify the request was sent.
• Track your PA with a reference number. Every PA submission should generate a tracking or reference number. Write it down. Use it when calling the insurer for status updates.
• Request expedited review when appropriate. If your symptoms are worsening or you face a gap in treatment, ask your doctor to file an urgent PA request with clinical justification for the urgency.
• Keep copies of everything. Document every phone call with the date, time, name of the representative, and what was discussed. Save all letters and faxes. This record becomes critical evidence if you need to appeal.
• Know your financial assistance options. While waiting for PA approval, explore manufacturer assistance programs and charitable foundations that may provide bridge coverage.

The prior authorization process can feel like an obstacle between you and the treatment your doctor has prescribed. It is frustrating, and that frustration is valid. But understanding the system gives you leverage. Patients who know the rules, track deadlines, and advocate for themselves are far more likely to get their treatments approved, and approved faster.

You are not powerless in this process. You have the right to appeal, the right to an external review, and the right to file regulatory complaints. Use them.